Ovarian Cancer Drugs Market: Driven by Large Number of Therapeutics in Developmental Stage
Ovarian cancer is a term attributed to the uncommon type of cancer that arises in the ovary of a woman from different types of cells. Ovarian cancer is caused due to the mutagenic changes in DNA. Inherited mutations in genes are also responsible for ovarian cancer. The risk of developing ovarian cancer is high if a woman has inherited mutations in the BRCA1 and BRCA2 genes.
View full press release